Aurélie Caye‐Eude

The KMT2A recombinome of acute leukemias in 2023

Claus Meyer, Patrizia Larghero, Bruno A. Lopes et al. · Leukemia · 2023 · 216 citations · Full text

Life Sciences, Genetics, Molecular Genetics +17

Determinants of CD19-positive vs CD19-negative relapse after tisagenlecleucel for B-cell acute lymphoblastic leukemia

Marie-Émilie Dourthe, Florence Rabian, Karima Yakouben et al. · Leukemia · 2021 · 150 citations

Medicine, Hematology, Oncology +14

B-ALL With t(5;14)(q31;q32); IGH-IL3 Rearrangement and Eosinophilia: A Comprehensive Analysis of a Peculiar IGH-Rearranged B-ALL

Benjamin Fournier, Estelle Balducci, Nicolas Duployez et al. · Frontiers in Oncology · 2019 · 40 citations · Full text

Life Sciences, Genetics, Hematology +15

Genetic alterations and MRD refine risk assessment for <i>KMT2A</i>-rearranged B-cell precursor ALL in adults: a GRAALL study

Rathana Kim, Hugo Bergugnat, Cédric Pastoret et al. · Blood · 2023 · 29 citations · Full text

Life Sciences, Genetics, Molecular Genetics +11

Novel Diagnostic and Therapeutic Options for KMT2A-Rearranged Acute Leukemias

Bruno A. Lopes, Caroline P. Poubel, Cristiane Esteves Teixeira et al. · Frontiers in Pharmacology · 2022 · 28 citations · Full text

Life Sciences, Genetics, Oncology +17